Leuthold Group’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.54M | Buy |
18,055
+128
| +0.7% | +$64.4K | 0.91% | 28 |
|
|
2025
Q4 | $8.37M | Buy |
17,927
+1,772
| +11% | +$823K | 0.9% | 33 |
|
|
2025
Q3 | $6.89M | Buy |
16,155
+549
| +4% | +$213K | 0.75% | 47 |
|
|
2025
Q2 | $5.98M | Sell |
15,606
-2,246
| -13% | -$809K | 0.71% | 50 |
|
|
2025
Q1 | $6.17M | Sell |
17,852
-1,177
| -6% | -$379K | 0.8% | 41 |
|
|
2024
Q4 | $5.71M | Sell |
19,029
-681
| -3% | -$238K | 0.69% | 53 |
|
|
2024
Q3 | $8.01M | Sell |
19,710
-210
| -1% | -$76.9K | 0.89% | 38 |
|
|
2024
Q2 | $6.4M | Buy |
19,920
+1,648
| +9% | +$535K | 0.74% | 47 |
|
|
2024
Q1 | $6.09M | Sell |
18,272
-10
| -0.1% | -$3.06K | 0.69% | 52 |
|
|
2023
Q4 | $4.95M | Sell |
18,282
-40
| -0.2% | -$9.89K | 0.62% | 62 |
|
|
2023
Q3 | $4.51M | Buy |
+18,322
| New | +$5.01M | 0.63% | 62 |
|
|
2022
Q1 | – | Sell |
-952
| Closed | -$245K | – | 205 |
|
|
2021
Q4 | $245K | Sell |
952
-51,035
| -98% | -$12.5M | 0.03% | 187 |
|
|
2021
Q3 | $12.6M | Buy |
51,987
+152
| +0.3% | +$37.2K | 1.55% | 15 |
|
|
2021
Q2 | $10.7M | Sell |
51,835
-973
| -2% | -$198K | 1.32% | 19 |
|
|
2021
Q1 | $9.95M | Sell |
52,808
-4,808
| -8% | -$848K | 1.25% | 20 |
|
|
2020
Q4 | $9.48M | Sell |
57,616
-2,852
| -5% | -$417K | 1.25% | 21 |
|
|
2020
Q3 | $7.54M | Sell |
60,468
-1,195
| -2% | -$148K | 1.03% | 30 |
|
|
2020
Q2 | $5.99M | Sell |
61,663
-1,540
| -2% | -$160K | 0.89% | 37 |
|
|
2020
Q1 | $5.68M | Sell |
63,203
-5,455
| -8% | -$706K | 1.02% | 29 |
|
|
2019
Q4 | $10.1M | Sell |
68,658
-2,619
| -4% | -$352K | 1.32% | 19 |
|
|
2019
Q3 | $8.58M | Sell |
71,277
-3,741
| -5% | -$483K | 1.12% | 23 |
|
|
2019
Q2 | $10.1M | Sell |
75,018
-5,073
| -6% | -$641K | 1.31% | 19 |
|
|
2019
Q1 | $10.4M | Sell |
80,091
-31,332
| -28% | -$4.21M | 1.4% | 15 |
|
|
2018
Q4 | $13.9M | Sell |
111,423
-12,935
| -10% | -$1.74M | 1.99% | 5 |
|
|
2018
Q3 | $17.3M | Buy |
124,358
+7,844
| +7% | +$976K | 1.89% | 7 |
|
|
2018
Q2 | $12M | Buy |
+116,514
| New | +$11.8M | 1.32% | 13 |
|
|
2017
Q3 | – | Sell |
-54,405
| Closed | -$4.74M | – | 205 |
|
|
2017
Q2 | $4.74M | Buy |
+54,405
| New | +$4.6M | 0.51% | 70 |
|
|
2016
Q3 | – | Sell |
-54,881
| Closed | -$4.23M | – | 225 |
|
|
2016
Q2 | $4.23M | Buy |
+54,881
| New | +$4.33M | 0.45% | 89 |
|
|
2015
Q4 | – | Sell |
-165,026
| Closed | -$12.8M | – | 200 |
|
|
2015
Q3 | $12.8M | Sell |
165,026
-23,286
| -12% | -$2.06M | 1.35% | 12 |
|
|
2015
Q2 | $17.1M | Buy |
188,312
+8,345
| +5% | +$669K | 1.6% | 5 |
|
|
2015
Q1 | $13.5M | Sell |
179,967
-1,440
| -0.8% | -$103K | 1.26% | 16 |
|
|
2014
Q4 | $13.3M | Buy |
181,407
+9,675
| +6% | +$680K | 1.31% | 13 |
|
|
2014
Q3 | $12.1M | Buy |
+171,732
| New | +$11.3M | 1.09% | 15 |
|
|
2013
Q4 | – | Sell |
-137,662
| Closed | -$5.88M | – | 252 |
|
|
2013
Q3 | $5.88M | Sell |
137,662
-6,982
| -5% | -$273K | 0.54% | 62 |
|
|
2013
Q2 | $5.22M | Buy |
+144,644
| New | +$5.6M | 0.48% | 70 |
|
Other funds holding HCA
VCM
VPM
Leuthold Group's HCA Position: Q1 2026 in Review
Leuthold Group increased its HCA Healthcare (HCA) stake by 0.71% in Q1 2026, buying an estimated $64.4K and bringing the position to 18,055 shares worth $8.54M. The position accounts for 0.91% of the portfolio, ranked #28.
Leuthold Group first reported a position in HCA in Q2 2013 and has held it in 35 quarters since. The position peaked at $17.3M in Q3 2018. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Leuthold Group held 18,055 shares of HCA Healthcare worth $8.54M as of Q1 2026.
- Leuthold Group bought 128 HCA Healthcare shares in Q1 2026, an estimated $64.4K.
- HCA Healthcare made up 0.91% of Leuthold Group's portfolio in Q1 2026, its #28 holding.
- Leuthold Group first reported a position in HCA Healthcare in Q2 2013 and has held it in 35 quarters since.
- Leuthold Group's HCA Healthcare position peaked at $17.3M in Q3 2018.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Leuthold Group's 13F filing for Q1 2026, filed 6 May 2026.